---
title: "CC.US (CC.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CC.US/news.md"
symbol: "CC.US"
name: "CC.US"
parent: "https://longbridge.com/en/quote/CC.US.md"
datetime: "2026-03-07T07:57:09.754Z"
locales:
  - [en](https://longbridge.com/en/quote/CC.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CC.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CC.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/CC.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CC.US/news.md)


# CC.US (CC.US) — Related News

### [17:07 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC](https://longbridge.com/en/news/277993631.md)
*2026-03-05T22:08:56.000Z*
> Pomerantz Law Firm is investigating claims on behalf of investors of The Chemours Company (NYSE: CC) regarding potential

### [15:18 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC](https://longbridge.com/en/news/277091184.md)
*2026-02-26T20:19:08.000Z*
> Pomerantz Law Firm is investigating claims on behalf of investors of The Chemours Company (NYSE: CC) regarding potential

### [Chemours plans to offer $600M in senior notes due 2034, subject to market conditions.](https://longbridge.com/en/news/277056846.md)
*2026-02-26T13:59:28.000Z*
> In Wilmington, Delaware, on February 26, 2026, Chemours Company (NYSE: CC) disclosed its plan to propose $600,000,000 in

### [Key facts: Goldman Sachs raises Chemours target to $18; Chemours partners with Solstice](https://longbridge.com/en/news/276932757.md)
*2026-02-25T20:04:11.000Z*
> Goldman Sachs raised the price target for Chemours (CC) to $18.00 per share, an increase from the previous target of $14

### [Following Successful Fluid Qualification Chemours & 2CRSi Join Forces to Accelerate Deployment of Two-Phase Liquid Cooling for High-Density Servers & IT Equipment](https://longbridge.com/en/news/276791877.md)
*2026-02-24T21:30:00.000Z*
> Chemours and 2CRSi have announced a Joint Development Agreement following the successful qualification of Chemours' Opte

### [Key facts: Chemours reports $5.8B sales, $386M loss; UBS raises price target](https://longbridge.com/en/news/276780814.md)
*2026-02-24T20:04:22.000Z*
> Chemours Co's annual Form 10-K report reveals net sales of $5,808 million for the year, alongside a net loss of $(386) m